Barclays’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,688
Closed -$22.6K 5557
2025
Q1
$22.6K Sell
12,688
-51,361
-80% -$115K ﹤0.01% 4774
2024
Q4
$109K Buy
64,049
+19,436
+44% +$57.4K ﹤0.01% 4573
2024
Q3
$152K Sell
44,613
-142
-0.3% -$526 ﹤0.01% 4434
2024
Q2
$179K Sell
44,755
-68,281
-60% -$234K ﹤0.01% 3631
2024
Q1
$385K Sell
113,036
-10,759
-9% -$33.6K ﹤0.01% 3751
2023
Q4
$418K Buy
123,795
+19,205
+18% +$98.8K ﹤0.01% 3993
2023
Q3
$564K Sell
104,590
-312
-0.3% -$2.15K ﹤0.01% 2720
2023
Q2
$986K Buy
104,902
+654
+0.6% +$6.18K ﹤0.01% 2318
2023
Q1
$1.02M Sell
104,248
-1,645
-2% -$18.5K ﹤0.01% 2718
2022
Q4
$1.32M Buy
105,893
+3,730
+4% +$45.8K ﹤0.01% 2575
2022
Q3
$929K Buy
102,163
+482
+0.5% +$3.54K ﹤0.01% 2299
2022
Q2
$262K Sell
101,681
-1,092
-1% -$4.31K ﹤0.01% 3289
2022
Q1
$722K Buy
+102,773
New +$1.36M ﹤0.01% 2643

Other funds holding VIGL